Literature DB >> 3061627

Myopathy in primary systemic amyloidosis.

M E Roke1, W F Brown, D Boughner, L C Ang, G P Rice.   

Abstract

Involvement of the peripheral nervous system by amyloidosis is common. It is less well recognized that amyloid can directly infiltrate and weaken skeletal muscle. We report a case of a 73-year-old woman, known to have cardiac amyloidosis, who developed profound weakness secondary to amyloid myopathy. Review of the 8 other well documented cases in the literature has revealed a rather homogeneous syndrome. Proximal weakness, muscle stiffness, pseudohypertrophy and myalgia constitute the principal features. This syndrome usually develops in cases with well recognized generalized amyloidosis. Amyloid is deposited within the basal lamina of blood vessels and muscle fibers.

Entities:  

Mesh:

Year:  1988        PMID: 3061627     DOI: 10.1017/s0317167100027815

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  4 in total

1.  Myopathy in primary systemic amyloidosis.

Authors:  M A Gertz; R A Kyle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

2.  Chronic myopathy due to immunoglobulin light chain amyloidosis.

Authors:  Irini Manoli; Justin Y Kwan; Qian Wang; Elisabeth J Rushing; Maria Tsokos; Andrew E Arai; Warner M Burch; Angela Dispenzieri; Alexandra C McPherron; William A Gahl
Journal:  Mol Genet Metab       Date:  2013-02-04       Impact factor: 4.797

3.  Bladder perforation secondary to primary systemic amyloidosis.

Authors:  Christopher J Dru; Tom S Feng; Howard H Kim
Journal:  Case Rep Urol       Date:  2014-12-22

4.  Muscle involvement with pseudohypertrophy in systemic light chain amyloidosis: Case report.

Authors:  Mirela Draghici; Andreea Jercan; Sorina Nicoleta Badelita; Ruxandra Maria Irimia; Alexandra Eugenia Bastian; Camelia Dobrea; Monica Popescu; Daniel Coriu
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.